ModerateSynergy
Hydrochlorothiazide can lower serum potassium through renal potassium wasting. Potassium repletion can be clinically useful when levels are low, but dose should be guided by labs because excess potassium can be dangerous, especially with kidney disease or RAAS-blocking drugs.
Recommendation: Have potassium checked after starting or changing hydrochlorothiazide and periodically during chronic therapy. Prefer dietary potassium unless your prescriber recommends a supplement; do not self-start high-dose potassium.
ModerateSynergy
HCTZ increases renal magnesium excretion, and chronic use can lead to hypomagnesemia. Magnesium depletion can worsen potassium depletion (refractory hypokalemia) and increase the risk of cardiac arrhythmias, especially in patients also taking digoxin.
Recommendation: Monitor magnesium levels during chronic HCTZ therapy. Consider magnesium supplementation (200-400mg/day), especially if potassium levels are difficult to correct. Magnesium repletion often helps resolve resistant hypokalemia.
SeriousCaution
Thiazide diuretics reduce lithium clearance by 25-40%, significantly increasing the risk of lithium toxicity. This is one of the most well-documented drug-drug interactions involving lithium.
Recommendation: If combination is necessary, reduce lithium dose by 25-50% and monitor lithium levels frequently (weekly initially). Use lowest effective diuretic dose.
ModerateSynergy
Hydrochlorothiazide can increase renal magnesium excretion during chronic therapy. Magnesium citrate may help replace magnesium if levels fall, and magnesium repletion may also help correct diuretic-related low potassium. Risk is higher in older adults, people with low dietary magnesium intake, and those on long-term diuretic therapy.
Recommendation: Ask for periodic magnesium and potassium checks if you use hydrochlorothiazide long term. Use magnesium citrate as replacement when labs or symptoms support it, and avoid high-dose magnesium if you have kidney disease unless supervised.
ModerateSynergy
Hydrochlorothiazide may gradually lower magnesium status by increasing urinary losses. Magnesium malate can help replenish magnesium when supplementation is appropriate. The combination is usually intentional and helpful, but magnesium replacement should still be monitored in kidney disease.
Recommendation: If you take hydrochlorothiazide and develop cramps, weakness, palpitations, or persistent low potassium, ask whether magnesium should be checked. Use magnesium malate consistently and avoid large unsupervised doses if your kidney function is reduced.
ModerateSynergy
Hydrochlorothiazide can produce chronic magnesium wasting, and magnesium taurate provides magnesium that may help restore stores. This is most relevant when hydrochlorothiazide also causes low potassium or when symptoms suggest electrolyte depletion. Kidney impairment increases the risk of excess magnesium from supplementation.
Recommendation: Use magnesium taurate as a monitored replacement strategy rather than as a substitute for lab checks. Ask for magnesium and potassium monitoring after dose changes or if you have cramps, weakness, palpitations, or recurrent low potassium.
ModerateCaution
Hydrochlorothiazide reduces urinary calcium excretion and can raise serum calcium. Adding high-dose calcium supplements can increase the risk of hypercalcemia, especially in older adults or people with kidney disease, hyperparathyroidism, dehydration, or heavy calcium antacid use. Symptoms can include nausea, constipation, thirst, confusion, kidney injury, and rhythm problems when severe.
Recommendation: Avoid high-dose calcium supplementation while taking hydrochlorothiazide unless your prescriber recommends it. Keep total calcium intake within your goal range and ask for serum calcium monitoring if you use calcium daily, have kidney stones, or develop hypercalcemia symptoms.
ModerateCaution
Hydrochlorothiazide can raise serum calcium by reducing urinary calcium loss, while Vitamin D3 increases intestinal calcium absorption. Standard Vitamin D3 doses are often tolerated, but high-dose supplementation can increase hypercalcemia risk in people with kidney disease, hyperparathyroidism, sarcoidosis, or high calcium intake. The risk is mainly a lab and dose-monitoring issue rather than a timing issue.
Recommendation: Use conservative Vitamin D3 dosing unless your clinician is monitoring calcium and 25-hydroxyvitamin D. If you take hydrochlorothiazide plus daily or high-dose Vitamin D3, ask whether serum calcium should be checked after starting or changing doses.
ModerateCaution
Hydrochlorothiazide reduces urinary calcium excretion, and Vitamin D2 can increase calcium absorption after conversion to active vitamin D metabolites. The concern is hypercalcemia when Vitamin D2 is taken in high doses or combined with high calcium intake. People with kidney disease, hyperparathyroidism, granulomatous disease, or dehydration are at higher risk.
Recommendation: Do not combine hydrochlorothiazide with high-dose Vitamin D2 without a monitoring plan. Ask for serum calcium monitoring after starting or changing Vitamin D2, especially if you also take calcium or have a history of kidney stones.
ModerateCaution
Hydrochlorothiazide lowers blood pressure partly through natriuresis and reduced plasma volume. Alcohol can potentiate orthostatic hypotension, so combining them may increase dizziness, fainting, falls, and dehydration risk. The risk is greater after starting hydrochlorothiazide, after dose increases, during illness, or with inadequate fluid intake.
Recommendation: Limit alcohol when starting or changing hydrochlorothiazide. If you drink, hydrate appropriately, stand slowly, and avoid heavy intake; stop and seek medical advice if you faint or have persistent lightheadedness.
ModerateCaution
L-Arginine can lower blood pressure through nitric-oxide-mediated vasodilation. Hydrochlorothiazide is an antihypertensive diuretic, so adding L-Arginine can drop blood pressure further than intended in some people. This is most relevant if your blood pressure is already at goal, you are older, dehydrated, or taking multiple blood-pressure medicines.
Recommendation: Start L-Arginine at a low dose if you take hydrochlorothiazide and monitor home blood pressure for 1-2 weeks. Reduce or stop it and contact your prescriber if you develop lightheadedness, fainting, unusual fatigue, or readings below your usual range.
ModerateCaution
L-Citrulline can increase arginine availability and modestly lower systolic blood pressure. Hydrochlorothiazide also lowers blood pressure, so the combination may cause lightheadedness or readings below your usual range. Risk is higher with dehydration, low sodium intake, older age, or multiple antihypertensive medications.
Recommendation: If you add L-Citrulline while taking hydrochlorothiazide, start with a low dose and track blood pressure for 1-2 weeks. Reduce or stop it if you develop dizziness, fainting, or unusually low readings.
NutriStack